| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 514.67M | 483.11M | 426.97M | 366.89M | 250.73M | 224.19M |
| Gross Profit | 325.54M | 294.58M | 258.90M | 235.79M | 163.97M | 154.06M |
| EBITDA | 56.07M | 25.76M | 28.75M | 44.83M | 5.82M | 31.85M |
| Net Income | 24.79M | 56.00K | 10.06M | 20.08M | -1.17M | 13.73M |
Balance Sheet | ||||||
| Total Assets | 702.84M | 684.93M | 687.00M | 654.63M | 515.37M | 427.55M |
| Cash, Cash Equivalents and Short-Term Investments | 328.69M | 298.32M | 290.85M | 228.04M | 231.19M | 212.71M |
| Total Debt | 50.84M | 48.91M | 51.42M | 57.53M | 55.23M | 16.59M |
| Total Liabilities | 262.26M | 289.65M | 235.45M | 249.27M | 197.18M | 146.36M |
| Stockholders Equity | 440.58M | 395.28M | 451.56M | 405.37M | 318.20M | 281.19M |
Cash Flow | ||||||
| Free Cash Flow | 102.06M | 90.15M | 78.31M | 6.08M | 16.03M | 47.31M |
| Operating Cash Flow | 108.72M | 94.45M | 80.64M | 23.79M | 49.30M | 62.49M |
| Investing Cash Flow | -74.55M | -12.97M | -68.40M | -72.76M | -34.05M | -80.13M |
| Financing Cash Flow | -54.81M | -79.67M | -12.23M | 26.04M | 5.75M | 17.48M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | C$4.72B | 136.84 | 8.24% | ― | 15.11% | 75.40% | |
71 Outperform | $1.15B | 15.45 | 12.56% | 6.27% | 0.03% | -10.21% | |
67 Neutral | $10.17B | 49.17 | 10.54% | ― | 15.63% | 18.47% | |
67 Neutral | C$12.28B | 18.26 | 12.32% | 2.76% | -5.01% | 13.21% | |
65 Neutral | $945.28M | 31.31 | 49.99% | ― | 16.25% | 31.71% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | C$2.15B | -2.48 | -37.01% | ― | 17.23% | -435.45% |
Kinaxis Inc. has announced its intention to initiate a normal course issuer bid, allowing the company to repurchase up to 5% of its outstanding shares over the next year. This move, approved by the Toronto Stock Exchange, is aimed at enhancing shareholder value by potentially increasing equity interest for remaining shareholders through share cancellation, reflecting the company’s confidence in its underlying business value.
The most recent analyst rating on (TSE:KXS) stock is a Hold with a C$201.00 price target. To see the full list of analyst forecasts on Kinaxis Inc stock, see the TSE:KXS Stock Forecast page.
Kinaxis Inc. reported a strong third quarter for 2025, with significant growth in SaaS revenue and Annual Recurring Revenue (ARR), both increasing by 17%. The company launched its initial Maestro Agents, which are expected to create a new revenue stream and improve customer outcomes. A notable early adopter, a top-10 global pharmaceutical company, has already seen a tenfold increase in planner productivity. The company’s financial performance and strategic initiatives position it well for continued growth and leadership in the supply chain sector.
The most recent analyst rating on (TSE:KXS) stock is a Hold with a C$201.00 price target. To see the full list of analyst forecasts on Kinaxis Inc stock, see the TSE:KXS Stock Forecast page.
Kinaxis Inc. reported a strong third quarter for 2025, with a 17% increase in SaaS revenue and Annual Recurring Revenue (ARR). The company launched its initial Maestro Agents, creating a new revenue stream and enhancing customer outcomes. This development, along with record Adjusted EBITDA and a robust AI product pipeline, positions Kinaxis well for future growth and strengthens its market leadership in the supply chain industry.
The most recent analyst rating on (TSE:KXS) stock is a Hold with a C$201.00 price target. To see the full list of analyst forecasts on Kinaxis Inc stock, see the TSE:KXS Stock Forecast page.
Kinaxis Earnings Call Highlights Strong Growth and Optimism